Hypertension, Stroke, Transient Ischemic Attack
Conditions
Keywords
stroke, transient ischemic attack, High blood pressure, Hypertension
Brief summary
The Stroke CTI study is a 3 arm randomized, controlled trial designed to assess the effectiveness of a nurse practitioner (NP) only and a NP and health coach (HC) community transitions intervention (CTI) in reducing secondary stroke risk by helping patients lower their systolic blood pressure.
Detailed description
Targeted study participants are Black and Hispanic patients with a history of stroke and a current systolic blood pressure (BP) above JNC7 recommended range (\>=140 mmHg) who recently entered home care service. The NP only program will provide a 30 day intervention while the NP/HC team will provide 3 months of support via in-home and telephone encounters for patients randomized to one of these groups. In the first 30 days post-enrollment the NP will focus on medical case management and coordination with primary care providers and specialists, provide self-management coaching, and intervene if gaps in care are identified - all with a focus on BP reduction and preparing the patient for ongoing BP maintenance. As applicable, the HC will pick up the case after 30 days and follow up with the plan of care jointly established by the patient, NP and HC. The focus will be on ongoing self-management coaching, providing preparation support for physician visits, and linking patient to additional community resources, as needed.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Newly admitted to the VNSNY post acute care program * 21 years of age or older * Black and/or Hispanic * Speaks English or Spanish * History of stroke or transient ischemic attack (TIA) * Hypertension diagnosis * Average screening systolic BP \>= 140 mmHg * Is available to participate in intervention activities during the study timeframe if randomized to treatment group
Exclusion criteria
* Dialysis * End stage renal disease * Kidney transplant * Severe heart failure * Significant cognitive impairment. Unable to provide informed consent, accurate self-report, and/or unable to participate effectively in intervention * Significant verbal speech impairment. Unable to participate in intervention telephone sessions * Patients with upper arm circumference outside of valid use parameters for the automated device used for eligibility screening
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Reduction of systolic blood pressure | Baseline to 3 and 12 months. | Patients randomized to the NP only and the NP+HC transitional care interventions will have greater 3 and 12 month reduction in SBP than patients in Usual Home Care. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cost-effectiveness of NP-only and NP+HC relative to UHC | VNSNY home care admission to 3 and 12 months post admission | Both interventions will be more costly but more cost-effective than usual home care. |
| Influence on post-stroke patients' function and health-related quality of life (QoL) | Baseline to 3 and 12 months | Both interventions will yield significant comparative improvements in function and health-related QoL; NP+HC will be more effective than NP-only. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Moderators and mediators that may affect treatment outcomes | Baseline to 3 and 12 months | Exploratory aim to examine potential moderating/mediating variables which may include: moderators - race/ethnicity (i.e., Black/Hispanic differences), baseline HTN severity (Stage I vs. Stage II); mediators - 1) changes in health behaviors (i.e., diet, physical activity, weight loss, medication adherence); and 2) antihypertensive medication intensification (i.e., adding, changing dose, or changing class of medications). |
Countries
United States